%0 Journal Article %J PloS one %D 2012 %T Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. %A Springer, Sandra A %A Qiu, Jingjun %A Saber-Tehrani, Ali Shabahang %A Altice, Frederick L %K Adult %K Buprenorphine %K Female %K HIV Infections %K Humans %K Male %K Middle Aged %K Naloxone %K Opioid-Related Disorders %K Prisoners %K Prospective Studies %K Treatment Outcome %N 5 %P e38335 %R 10.1371/journal.pone.0038335 %V 7 %X HIV-infected prisoners lose viral suppression within the 12 weeks after release to the community. This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD). %8 2012